ロード中...
Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects
The inefficiency of recombinant tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-based clinical regimens has been dominantly attributed to the short half-life of TRAIL. Affinity-controlled release using endogenous long-acting proteins, such as IgG and albumin, as carriers is extremely...
保存先:
| 出版年: | Theranostics |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5928902/ https://ncbi.nlm.nih.gov/pubmed/29721092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.23880 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|